Clinical Trial Update: Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating switching virologically suppressed HIV-1 adults with ETR resistance from etravirine to doravirine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Doravirine (doravirine)
• etravirine (etravirine)

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: HIV-1-infection | Phase 4 | Status: UNKNOWN